Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.

Gupta JK, Daniels JP, Middleton LJ, Pattison HM, Prileszky G, Roberts TE, Sanghera S, Barton P, Gray R, Kai J; ECLIPSE Collaborative Group.

Health Technol Assess. 2015 Oct;19(88):i-xxv, 1-118. doi: 10.3310/hta19880.

2.

Levonorgestrel intrauterine system versus medical therapy for menorrhagia.

Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J; ECLIPSE Trial Collaborative Group.

N Engl J Med. 2013 Jan 10;368(2):128-37. doi: 10.1056/NEJMoa1204724.

3.

EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemia-reperfusion-induced damage.

Gianello P, Saliez A, Bufkens X, Pettinger R, Misseleyn D, Hori S, Malfroy B.

Transplantation. 1996 Dec 15;62(11):1664-6.

PMID:
8970624

Supplemental Content

Loading ...
Support Center